A dose a day keeps the cancer away: metronomic albumin-bound paclitaxel and topotecan has potent antitumor activity in ovarian cancer

Davis, Ashley

171 - Poster Session A
A dose a day keeps the cancer away: metronomic albumin-bound paclitaxel and topotecan has potent antitumor activity in ovarian cancer

Saturday, March 22, 2014: 7:05 PM

West Exhibit Hall (Tampa Convention Center)

A. N. Davis¹, Y. G. Lin², R. A. Previs¹, H. J. Dalton¹, R. L. Stone³, J. N. Bottsford-Miller¹, B. Zand¹, R. L. Coleman¹, A. K. Sood¹ and M. Taylor¹
¹The University of Texas MD Anderson Cancer Center, Houston, TX, ²University of Southern California, Los Angeles, CA, ³University of Arkansas for Medical Sciences, Little Rock, AR

45th Annual Meeting on Women's Cancer

March 21 - 25, 2014

Navigation

171 - Poster Session A
A dose a day keeps the cancer away: metronomic albumin-bound paclitaxel and topotecan has potent antitumor activity in ovarian cancer

171 - Poster Session A A dose a day keeps the cancer away: metronomic albumin-bound paclitaxel and topotecan has potent antitumor activity in ovarian cancer

171 - Poster Session A
A dose a day keeps the cancer away: metronomic albumin-bound paclitaxel and topotecan has potent antitumor activity in ovarian cancer